(Stroke. 2002;33:286.)
© 2002 American Heart Association, Inc.
Research Reports |
, MDFrom the Department of Neurology, Hacettepe University Hospital, Ankara, Turkey.
Correspondence to Hakan Ay, MD, Hacettepe University Hospitals, Department of Neurology, Sihhiye 06100, Ankara-Turkey. E-mail ayhmgh{at}hotmail.com
Abstract
Background and Purpose Creatine kinase-MB (CK-MB) increases in some patients with stroke, with no clear evidence of an acute coronary syndrome. Its elevations have been suggested to represent a biological marker for stroke-related myocardial injury. Troponin T has superior sensitivity and specificity to CK-MB in revealing minor myocardial injury. Therefore, we studied troponin T levels after stroke to determine whether troponin T increases in parallel to CK-MB.
Methods We made daily measurements of CK-MB, myoglobin, total creatine kinase (total CK), and troponin T levels up to day 5 in 32 patients with large hemispheric infarction and with no history of coronary heart disease. The daily enzyme levels were compared with those of a control group of 22 patients with neurological diseases other than stroke.
Results Serum CK-MB, myoglobin, and total CK levels were elevated above the cutoff value in 11, 26, and 20 patients with stroke, respectively. These enzyme levels gradually increased within the first 3 days and declined afterward. Troponin T did not exceed the reference range in any patients. One patient had elevated myoglobin and 3 had elevated total CK in the control group. The difference between groups was significant for CK-MB, myoglobin, and total CK at various time points.
Conclusions Troponin T, a more specific biochemical marker of myocardial injury, does not increase after stroke. Normal troponin T along with elevated CK-MB signifies that CK-MB is not the biological marker for myocytolysis. CK-MB elevations in stroke patients are likely to be noncardiac in origin.
Key Words: creatine kinase-MB myocardial infarction stroke, ischemic troponin T
This article has been cited by other articles:
![]() |
W. E. Kelley, J. L. Januzzi, and R. H. Christenson Increases of Cardiac Troponin in Conditions other than Acute Coronary Syndrome and Heart Failure Clin. Chem., December 1, 2009; 55(12): 2098 - 2112. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Sugg, N. R. Gonzales, D. E. Matherne, M. Ribo, H. M. Shaltoni, S. Baraniuk, E. A. Noser, and J. C. Grotta Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa. Neurology, September 26, 2006; 67(6): 1053 - 1055. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ay, W. J. Koroshetz, T. Benner, M. G. Vangel, C. Melinosky, E. M. Arsava, C. Ayata, M. Zhu, L. H. Schwamm, and A. G. Sorensen Neuroanatomic correlates of stroke-related myocardial injury Neurology, May 9, 2006; 66(9): 1325 - 1329. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Anderson Candidate-based proteomics in the search for biomarkers of cardiovascular disease J. Physiol., February 15, 2005; 563(1): 23 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Etgen, H. Baum, K. Sander, and D. Sander Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide in Acute Ischemic Stroke Do Not Relate to Clinical Prognosis Stroke, February 1, 2005; 36(2): 270 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dittmar, T. Spruss, G. Schuierer, and M. Horn External Carotid Artery Territory Ischemia Impairs Outcome in the Endovascular Filament Model of Middle Cerebral Artery Occlusion in Rats Stroke, September 1, 2003; 34(9): 2252 - 2257. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Butcher, M. W. Parsons, H. Ay, E. M. Arsava, and O. Saribas Cardiac Enzyme Elevations After Stroke: The Importance of Specificity * Response Stroke, August 1, 2002; 33(8): 1944 - 1945. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |